Crescent Biopharma (CBIO) Cash & Equivalents (2013 - 2026)
Crescent Biopharma (CBIO) recorded Cash & Equivalents of $171.6 million in Q2 2026, up 12.4% from $152.65 million a year earlier but down 9.3% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Crescent Biopharma reported Cash & Equivalents of $213.19 million, up 513.2% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 9.2% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $34.77 million in FY2024 (-16.8%), $41.79 million in FY2023 (-12.7%), $47.87 million in FY2022 (-47.0%) and $90.25 million in FY2021 (-34.1%).
- Quarterly Cash & Equivalents has ranged from $14.4 million in Q3 2024 to $213.19 million in Q4 2025 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for five consecutive quarters, with growth averaging 320.0% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 825.7% in Q3 2025, against a decline of 70.9% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $189.2 million (Q1 2026), $213.19 million (Q4 2025) and $133.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Crescent Biopharma | 404.96 Mn | -302.33 Mn | - | 171.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 171.60 Mn |
| Mar 31, 2026 | 189.20 Mn |
| Dec 31, 2025 | 213.19 Mn |
| Sep 30, 2025 | 133.30 Mn |
| Jun 30, 2025 | 152.65 Mn |
| Mar 31, 2025 | 22.43 Mn |
| Dec 31, 2024 | 34.77 Mn |
| Sep 30, 2024 | 14.40 Mn |
| Jun 30, 2024 | 22.40 Mn |
| Mar 31, 2024 | 31.30 Mn |
| Dec 31, 2023 | 41.79 Mn |
| Sep 30, 2023 | 49.41 Mn |
| Jun 30, 2023 | 58.04 Mn |
| Mar 31, 2023 | 65.00 Mn |
| Dec 31, 2022 | 47.87 Mn |
| Sep 30, 2022 | 51.62 Mn |
| Jun 30, 2022 | 60.24 Mn |
| Mar 31, 2022 | 76.52 Mn |
| Dec 31, 2021 | 90.25 Mn |
| Sep 30, 2021 | 101.92 Mn |
API Access
Crescent Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();